enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

3. Astellas Institute for Regenerative Medicine - Wikipedia

   en.wikipedia.org/wiki/Astellas_Institute_for...

   Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. [3]

4. Retinal implant - Wikipedia

   en.wikipedia.org/wiki/Retinal_implant

   A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).

5. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   Macular degeneration treatment is safe and effective. The FDA approval was based on a review of scientific evidence showing that both drugs are “highly similar” to Regeneron Pharmaceuticals’ ...

6. Masayo Takahashi - Wikipedia

   en.wikipedia.org/wiki/Masayo_Takahashi

   Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.

7. Human embryonic stem cells clinical trials - Wikipedia

   en.wikipedia.org/wiki/Human_embryonic_stem_cells...

   Two clinical trials involving derivatives of human embryonic stem cells were approved in 2010. Advanced Cell Technology (ACT) located in Marlborough, Massachusetts, leads the trials aimed at improving the vision of patients with Stargardt's Macular Dystrophy and Dry Age-Related Macular Degeneration.